TradingView
RocketTickers
8 nov 2019 17:06

Affimed Announces FDA Clearance of IND to Commence First-in-Huma Long

NASDAQ:AFMD1D
Affimed N.V.NASDAQ

Descrizione

⋅
AFMD: Affimed N.V.
2019-11-07 16:01:00
Affimed Announces FDA Clearance of IND to Commence First-in-Human Phase 1/2a Study of AFM24 for the Treatment of EGFR-Expressing Cancers
Beyond Technical Analysis
Altro